FEATURED POST
What You Can Learn from 7 Theme Fusion Success Stories
Nam lacinia arcu tortor, nec luctus nibh dignissim eu. Nulla sit amet maximus nulla. Pellentesque a accumsan eros, ac molestie nulla. Morbi interdum in neque vitae vulputate.
Innovative Therapies and Personalized Medicine for Rare Diseases: MOOC in Full Swing
As we are in full swing of the facilitation window in September, we're excited to share an update on the ongoing online [...]
Newsletter, June 2024
Dear Reader, Imagine a world where every child, regardless of their condition, has access to safe, effective, and child-friendly therapies. This [...]
RACE Act accelerates Paediatric Oncology Drug Testing, FDA reports
The U.S. Food and Drug Administration (FDA) has reported a significant increase in the number of planned studies to test drugs [...]
CVBF’s New Video Offers Insights into Multinational Rare Disease Clinical Trials
We are proud to share with you the newly released informative video detailing the challenges and strategies involved in conducting [...]
CVBF at the ERAMET Kick-Off Meeting
Namur, Belgium - CVBF participated in the kick-off meeting of the ERAMET project on March 4-5 in Namur that was [...]
29 February 2024, Rare Disease Day
29 February is Rare Disease Day, falling on the rarest date of the calendar. This is an opportunity to raise [...]
CVBF’s Scientific Director to Speak at Rare Disease & Orphan Drugs Congress
Giovanni Migliaccio, Scientific Director of CVBF and member of the Board of Directors of the European Paediatric Translational Research Infrastructure [...]
Quality Assurance Head, Mariagrazia Felisi, Leads Workshop on EU Clinical Trial Regulation
On 27 June 2023, Mariagrazia Felisi, our Quality Assurance Head and Internal Auditor, co-chairing the "AICRO Clinical Trial Center Working Group", opened and led the [...]
Advanced Therapies: A Researcher’s Perspective on ATMPs – Insights from Giovanni Migliaccio
Giovanni Migliaccio, the Scientific Director of CVBF, recently participated at the MEP Interest Group 2023 Conference organized by the European Alliance for Transformative Therapies (TRANSFORM) [...]
EUCROF Paediatric Training: Our CEO’s Vision for Advancing Paediatric Clinical Research
In the ever-advancing world of clinical research, staying at the forefront of knowledge and practices is imperative. On 12 September 2023, our CEO, Donato Bonifazi [...]
Developed tools for Rare Diseases researchers – ERICA & EJP RD Joint Conference
Bonka Georgieva, CVBF's Project Manager, presented at the "ERICA & EJP RD Joint Conference" held in Amsterdam. The event served as a platform for advancing [...]
XVI Foresight Training Course
Arianna Bertolani, our Head of Project and Development, will participate, as a speaker at the 16th Foresight Training Course entitled "Repurposing to cover unmet needs: [...]
CVBF’s Expertise in Phase I Clinical Trials: A Commitment to Excellence
Phase 1 trials, be they conducted on healthy volunteers or patients, focus on generation of initial knowledge on tolerability, safety and PK/PD.. These trials determine [...]